The main factors that should be taken into account are the physiological and social factors of women and the impact of antiepileptic treatment on the physiological function of patients. The use of anti-epileptic drugs in adolescent and young women should pay attention to the effect of drugs on sex hormones and menstrual cycle. Some female patients have seizures related to their menstrual cycle. For these patients, the dosage should be increased or short-term increased according to the menstrual cycle 2-3 days before menstruation, and then restored to the maintenance dosage after menstruation. For women in their childbearing years, if epilepsy has been effectively controlled, it is advisable to consider planning pregnancy after 6 months of drug discontinuation in female patients. If the medication cannot be discontinued, it should be adjusted to low-dose monotherapy as much as possible. 4. Female pregnant women with epilepsy should be monitored during follow-up to minimize seizures during pregnancy, and the blood concentration of antiepileptic drugs should be monitored regularly to reduce teratogenic effects on the fetus. 5. Female lactating patients with epilepsy should choose drugs with low breast milk filtration rate, such as lamotrigine and oxcarbazepine. In addition, lifestyle interventions are also very important for all epilepsy patients, who should maintain healthy habits and avoid exertion, hunger, emotional excitement or infection to maximize seizure control and reduce damage to the organism. In summary, in addition to adhering to standardized medication and life regulation, female epilepsy patients need to take into account the physiological peculiarities of women and strive to maintain or restore their original physiological and social functional status.